Acasti Pharma

After laying off most staff, Acasti insists it's still on track

Laying off most of your workforce is normally a sign of a biotech in a death spiral, but Acasti’s CEO is insistent the move has energized the company.

James Waldron Jun 23, 2023 8:22am

Amarin CEO abruptly resigns—Chutes & Ladders

Apr 7, 2023 9:30am

Acasti abandons omega-3 filing after 2nd phase 3 flop

Sep 1, 2020 9:20am